糖尿病的纳米材料:诊断,检测和交付
1Center for Precision Engineering, Harbin Institute of Technology, Harbin 150001, Heilongjiang, People's Republic of China.
Nanotechnology
|July 11, 2024
概括
纳米技术为糖尿病提供了有前途的解决方案,改善了葡萄糖管理和药物输送. 新型纳米载体系统,包括聚合物和基材料,显示出增强抗糖尿病治疗的潜力.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病影响全球5.37亿人,造成严重的心血管风险.
- 现有的糖尿病治疗方法面临着一些局限性,例如生物可用性差和患者坚持治疗.
- 纳米技术为先进的糖尿病药物治疗提供了一个有前途的途径.
研究的目的:
- 审查糖尿病治疗中纳米载体应用的最新进展.
- 探索各种纳米材料 (聚合物,陶,树脂,二氧化) 用于抗糖尿病药物输送.
- 突出纳米技术在改善葡萄糖管理方面的潜力.
主要方法:
- 关于胰岛素和抗糖尿病药物的纳米载体的文献综述.
- 使用聚合物纳米网络对葡萄糖介导释放系统的分析.
- 对基于二氧化的纳米载体和树枝体进行糖尿病治疗的检查.
主要成果:
- 一个可注射,可酸降解的聚合物纳米网络在1型糖尿病小鼠中证明了改善葡萄糖管理.
- 纳米粒子为有效的糖尿病治疗提供可调节的特性.
- 丹德里默在治疗糖尿病方面显示出潜在的作用.
结论:
- 纳米材料显著提高了糖尿病的诊断和治疗.
- 纳米技术在治疗糖尿病及其并发症方面具有巨大的未来前景.
- 自主调节的胰岛素输送系统显示出改善患者结果的希望.
更多相关视频
08:19Hollow Microneedle-based Sensor for Multiplexed Transdermal Electrochemical Sensing
Published on: June 1, 2012
14.4K
13:42Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
Published on: September 19, 2017
11.8K
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
